Loading
Yanuki
ARTICLE DETAIL
Delve Accused of Passing Off Open Source AI Tool as Its Own | Red Wings Honor Alex Delvecchio with Jersey Patch | Dancing With the Stars: Anna Delvey Shade and Weight Loss Journey | OneText Secures $4.5M to Revolutionize E-commerce with Text-to-Buy Network | Cheersy Raises $550K with Kerry Washington as Lead Investor | Hockey Legend Alex Delvecchio Passes Away at 93 | AI Startups Secure Funding for Innovation | Cluely: AI Cheating Tool Raises $5.3M in Seed Funding | Delve Accused of Passing Off Open Source AI Tool as Its Own | Red Wings Honor Alex Delvecchio with Jersey Patch | Dancing With the Stars: Anna Delvey Shade and Weight Loss Journey | OneText Secures $4.5M to Revolutionize E-commerce with Text-to-Buy Network | Cheersy Raises $550K with Kerry Washington as Lead Investor | Hockey Legend Alex Delvecchio Passes Away at 93 | AI Startups Secure Funding for Innovation | Cluely: AI Cheating Tool Raises $5.3M in Seed Funding

Startups / Compliance

Delve Accused of Passing Off Open Source AI Tool as Its Own

Compliance startup Delve is under scrutiny following accusations of improperly using an open-source AI tool. The company is alleged to have presented Sim.ai's SimStudio as its own proprietary 'Pathways' tool without proper licensing or attr...

The reputation of troubled YC startup Delve has gotten even worse
Share
X LinkedIn

delve
Delve Accused of Passing Off Open Source AI Tool as Its Own Image via TechCrunch

Key Insights

  • Delve allegedly passed off Sim.ai's open-source SimStudio as its own 'Pathways' tool without proper licensing.
  • Sim.ai's CEO, Emir Karabeg, confirmed Delve had no licensing agreement with Sim.ai, even though Sim.ai was a paying Delve customer.
  • The allegations surfaced from an anonymous whistleblower known as DeepDelver.
  • The controversy has triggered significant backlash on X (formerly Twitter), becoming a trending topic with community notes.
  • Insight Partners led a $32 million Series A funding round into Delve. Mentions of the Pathways tool on Delve’s site appear to have been removed.

In-Depth Analysis

The core issue revolves around Delve's 'Pathways' tool, which DeepDelver claims is a modified version of Sim.ai's SimStudio. If true, this violates the Apache software license, requiring the original developer to be credited. The situation is particularly ironic given Delve's focus on providing compliance solutions.

Sim.ai's founder stated that Delve had attempted to purchase an agreement but never properly licensed SimStudio. The removal of mentions of 'Pathways' from Delve's website further fuels speculation about the allegations' validity.

The incident raises questions about due diligence processes from investors like Insight Partners, who led Delve's Series A funding. The controversy underscores the importance of respecting open-source licenses and ethical conduct, especially for companies offering compliance services.

Read source article

FAQ

What is the main allegation against Delve?

Delve is accused of taking an open-source tool (SimStudio) and presenting it as their own proprietary tool (Pathways) without proper attribution or licensing.

Who is DeepDelver?

DeepDelver is the anonymous whistleblower who brought the allegations against Delve to light.

What is Sim.ai's role in this?

Sim.ai is the company whose open-source tool, SimStudio, was allegedly used by Delve without permission. Sim.ai was also a paying customer of Delve.

Takeaways

  • **Open Source Compliance:** Properly attributing and licensing open-source software to avoid legal and ethical issues.
  • **Due Diligence:** Thoroughly vetting the practices and technologies of companies, especially before significant investments.
  • **Ethical Conduct:** Maintaining transparency and integrity, particularly for companies offering compliance-related services.

Discussion

Do you think Delve's actions will have long-term consequences for the company? Share your thoughts in the comments below!

Share this article with others who need to stay ahead of this trend!

Sources

Disclaimer

This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.

All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.

This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.

Always do your own research (DYOR) before making any decisions based on the information presented.